Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta

Cell Reports

Volumn 5, Issue 3, 2013, Pages 646-653

  Michaud, Jean Philippe ^a   Bellavance, Marc André ^a   Préfontaine, Paul ^a   Rivest, Serge ^a  

^a University Laval   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; BRAIN CORTEX; CONTROLLED STUDY; ENDOSOME; HIPPOCAMPUS; IMAGING SYSTEM; IN VIVO STUDY; MACROPHAGE; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; ANIMAL; BLOOD; C57BL MOUSE; IMAGE PROCESSING; METABOLISM; MONONUCLEAR CELL; MULTIPHOTON MICROSCOPY; PATHOLOGY; PROCEDURES;

MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD VESSELS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE, MULTIPHOTON;

EID: 84887611153     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.10.010     Document Type: Article

References (34)

1. Bechmann I., Galea I., Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol. 2007, 28:5-11.
2. Bell R.D., Deane R., Chow N., Long X., Sagare A., Singh I., Streb J.W., Guo H., Rubio A., Van Nostrand W., et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat. Cell Biol. 2009, 11:143-153.
3. Bellavance M.-A., Blanchette M., Fortin D. Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J. 2008, 10:166-177.
4. Boissonneault V., Filali M., Lessard M., Relton J., Wong G., Rivest S. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 2009, 132:1078-1092.
5. Carlin L.M., Stamatiades E.G., Auffray C., Hanna R.N., Glover L., Vizcay-Barrena G., Hedrick C.C., Cook H.T., Diebold S., Geissmann F. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 2013, 153:362-375.
6. Cui Y., Le Y., Yazawa H., Gong W., Wang J.M. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J.Leukoc. Biol. 2002, 72:628-635.
7. Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2009, 8:16-30.
8. Dorr A., Sahota B., Chinta L.V., Brown M.E., Lai A.Y., Ma K., Hawkes C.A., McLaurin J., Stefanovic B. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain 2012, 135:3039-3050.
9. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., Lossinsky A.S., Graves M.C., Gustavson A., Sayre J., et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J.Alzheimers Dis. 2005, 7:221-232. discussion 255-262.
10. Fiala M., Liu P.T., Espinosa-Jeffrey A., Rosenthal M.J., Bernard G., Ringman J.M., Sayre J., Zhang L., Zaghi J., Dejbakhsh S., et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA 2007, 104:12849-12854.
11. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., Narni-Mancinelli E., Lauvau G. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 2008, 86:398-408.
12. Giri R., Shen Y., Stins M., Du Y.S., Schmidt A.M., Stern D., Kim K.S., Zlokovic B., Kalra V.K. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 2000, 279:C1772-C1781.
13. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., Geissmann F., Hedrick C.C. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 2011, 12:778-785.
14. Hawkes C.A., McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. USA 2009, 106:1261-1266.
15. Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., Nagelhus E.A., Nedergaard M. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 2012, 4. 147ra111.
16. Lampron A., Lessard M., Rivest S. Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain. Cell Transplant. 2012, 21:1149-1159.
17. Liu Z., Condello C., Schain A., Harb R., Grutzendler J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis. J.Neurosci. 2010, 30:17091-17101.
18. Majumdar A., Cruz D., Asamoah N., Buxbaum A., Sohar I., Lobel P., Maxfield F.R. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell 2007, 18:1490-1496.
19. Majumdar A., Chung H., Dolios G., Wang R., Asamoah N., Lobel P., Maxfield F.R. Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages. Neurobiol. Aging 2008, 29:707-715.
20. Marques M.A., Kulstad J.J., Savard C.E., Green P.S., Lee S.P., Craft S., Watson G.S., Cook D.G. Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system. J.Alzheimers Dis. 2009, 16:325-329.
21. Mawuenyega K.G., Sigurdson W., Ovod V., Munsell L., Kasten T., Morris J.C., Yarasheski K.E., Bateman R.J. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010, 330:1774.
22. Michaud J.-P., Hallé M., Lampron A., Thériault P., Préfontaine P., Filali M., Tribout-Jover P., Lanteigne A.-M., Jodoin R., Cluff C., et al. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc. Natl. Acad. Sci. USA 2013, 110:1941-1946.
23. Mildner A., Schlevogt B., Kierdorf K., Böttcher C., Erny D., Kummer M.P., Quinn M., Brück W., Bechmann I., Heneka M.T., et al. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J.Neurosci. 2011, 31:11159-11171.
24. Pimentel-Coelho P.M., Rivest S. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Eur. J. Neurosci. 2012, 35:1917-1937.
25. Prinz M., Priller J. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J.Neuroimmunol. 2010, 224:80-84.
26. Ransohoff R.M., Kivisäkk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
27. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 2007, 13:1359-1362.
28. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439.
29. Sehgal N., Gupta A., Valli R.K., Joshi S.D., Mills J.T., Hamel E., Khanna P., Jain S.C., Thakur S.S., Ravindranath V. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA 2012, 109:3510-3515.
30. Shen Z., Lu Z., Chhatbar P.Y., O'Herron P., Kara P. An artery-specific fluorescent dye for studying neurovascular coupling. Nat. Methods 2012, 9:273-276.
31. Simard A.R., Soulet D., Gowing G., Julien J.-P., Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49:489-502.
32. Weller R.O., Preston S.D., Subash M., Carare R.O. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther 2009, 1:6.
33. Yona S., Kim K.-W., Wolf Y., Mildner A., Varol D., Breker M., Strauss-Ayali D., Viukov S., Guilliams M., Misharin A., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
34. Zhang K., Tian L., Liu L., Feng Y., Dong Y.-B., Li B., Shang D.-S., Fang W.-G., Cao Y.-P., Chen Y.-H. CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease. PLoS ONE 2013, 8:e72744.